Friday, July 24, 2015 3:42:31 PM
Cowen analyst Ken Cacciatore aggressively boosted his price target on Inotek Pharmaceuticals (NASDAQ: ITEK) to $40.00
http://www.streetinsider.com/Analyst+Comments/Inotek+%28ITEK%29+Data+Unprecedented%2C+Buy+Aggressively%2C+Cowen+Says%3B+PT+to+%2440/10746181.html
Recent ITEK News
- HANetf ICAV Merger on HANetf ICAV sub-funds (Merger Ratio) • RNS Regulatory News • 03/28/2024 02:49:55 PM
- HANetf ICAV Notice of EGM Results • RNS Regulatory News • 03/19/2024 10:00:45 AM
- HANetf ICAV Notice of EGM • RNS Regulatory News • 02/26/2024 06:08:31 PM
Endexx Corporation (EDXC) Leverages Global Market Trends and Legislative Reforms to Spearhead Growth in the Cannabis and Plant-Based Wellness Sectors • EDXC • Mar 27, 2024 3:01 PM
Applied UV, Inc. Announces Pricing of $2.76 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules • AUVI • Mar 27, 2024 2:51 PM
POET and MultiLane Collaborate to Develop High-Speed Pluggable Transceivers for AI Networks • POET • Mar 27, 2024 10:52 AM
Maybacks Global Entertainment Opens 23 More Stations in Important Major Cities • AHRO • Mar 27, 2024 9:00 AM
NxGen Brands Inc. Forecast to Deliver 140% Growth in Q1 2024 • NXGB • Mar 27, 2024 7:30 AM
Kona Gold Beverages, Inc. Strategic Advancements: Covert LLC Introduces Federally Legal D9 Gummies and Revamps Innovative eCommerce Platform, Propelling Toward $12 Million Annual Revenue Goal • KGKG • Mar 26, 2024 8:30 AM